# The Influence of [18F]PMPBB3 and [18F]THK5351 PET Distribution Patterns on Post-stroke Cognitive Impairment

> **NCT04318626** · PHASE2 · UNKNOWN · sponsor: **Chang Gung Memorial Hospital** · enrollment: 80 (estimated)

## Conditions studied

- Post-stroke Cognitive Impairment
- Neuroinflammation

## Interventions

- **DRUG:** PMPBB3
- **DRUG:** THK5351

## Key facts

- **NCT ID:** NCT04318626
- **Lead sponsor:** Chang Gung Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-11-01
- **Primary completion:** 2023-07-31
- **Final completion:** 2024-07-31
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2023-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04318626

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04318626, "The Influence of [18F]PMPBB3 and [18F]THK5351 PET Distribution Patterns on Post-stroke Cognitive Impairment". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04318626. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*